Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Cristina Signes

Cristina Signes

Verified

Dr. Cristina Signes Pon is a specialist in Obstetrics and Gynecology Colegiado Number : 464623236 Clinical interests: General Gynaecology, Pelvic Floor Dysfunction, Urinary and Gynaecological Related Bowel Dysfunction, Pelvic Floor related Sexual Dysfunction, Urogynaecology, Specialist in Obstetrics and Gynecology. Dr. Cristina Signes Pons is a highly respected gynecologist with over a decade of experience, specializing in Obstetrics and Gynecology. After earning her medical degree from the prestigious University of Valencia in 2012, she completed her specialized residency training at the University and Polytechnic Hospital La Fe de Valencia in 2017. Dr. Signes is an active member of the Ilustre Colegio Oficial de Médicos de Valencia, with license number 464623236. With clinics in both Moraira and Javea and ongoing work at Denia Hospital, Dr. Signes has become a trusted name in women's healthcare throughout the region. Known for her compassionate approach, she offers personalized sexual health screenings and expert care in Gynecology, ensuring each patient feels comfortable and supported. She is also specially trained in delivering the cutting-edge NU-V treatment, offering innovative solutions tailored to individual needs. Whether it’s general gynecological care, maternity services, or specialized treatments, Dr. Cristina Signes Pons is dedicated to helping her patients make informed and empowered health decisions.

MD OB-GYN
Was this answer helpful?
Rate Cristina's explanation
0.0 (5)



Comfort first


Pain assessed


Intimacy support

Women’s Health Clinic FAQ

Does lichen sclerosus cause loss of libido?

Sexual comfort questions around lichen sclerosus need a careful answer because pain, friction, fear of tearing, libido and relationship strain can overlap.

Direct answer

Lichen sclerosus may contribute to loss of libido indirectly through pain, fear of tearing, dryness, body-image worry, fatigue from chronic symptoms or relationship strain. Desire may improve when comfort and confidence improve, but libido is multifactorial.

The safest page validates intimacy concerns while keeping disease control, pelvic-floor guarding, lubrication, pacing and red-flag review separate.


Educational only. Suitability and next steps should be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation about does lichen sclerosus cause loss of libido?

Sexual comfort

At a glance

These are the main points to understand before deciding what care or treatment pathway is appropriate.

At a glance

Practical clinical summary

Main area

Vulval comfort

Care pattern

Individual

Watch for

Pain or tearing

Next step

Supportive care

Important safety note

Symptoms in intimate areas should not be self-diagnosed from appearance alone. Assessment helps separate inflammation, low-oestrogen change, infection, pelvic-floor symptoms and skin conditions.

Assessment
Symptoms
Treatment options
Red flags
Follow-up




Detailed answer

Detailed answer

The deeper answer depends on matching the symptom to the right tissue and diagnosis. That is especially important when online pages blur vulval skin, vaginal tissue, prolapse and sexual discomfort.

Pain and avoidance

The reader wants validation around reduced desire without implying LS directly controls libido.

Cause
Diagnosis
Treatment
Review

Pain and avoidance

This is the first distinction to make because it shapes whether advice is about skin care, vaginal tissue, pelvic floor or specialist referral.

Fear of tearing

Symptoms should be interpreted alongside timing, severity, visible change, treatment history and whether the problem is new or worsening.

Body image and confidence

Treatment choices should be presented as options to discuss, not as a single automatic pathway.

Relationship strain

Follow-up matters when symptoms persist, recur, alter skin architecture or affect sex, urination, exercise or daily comfort.

How the research shapes the answer

Diagnostic Delays: Misdiagnosis is rampant; VLS is frequently misdiagnosed as recurrent thrush (candidiasis), menopause, or an STI, sometimes delaying correct treatment for years [19, 22, 23]. Dismissive Encounters: Patients frequently report disempowering encounters where.

The benchmark structure was used for search intent, but the final wording is deliberately more cautious than promotional clinic pages.





Patient safety

Why this distinction matters

Many intimate-health symptoms sound similar online, but the safest treatment plan depends on the underlying cause.

It avoids missed diagnosis

Itching, burning, dryness, pain or white skin change can point to different conditions that need different care.

It protects treatment choice

Supportive measures, prescribed treatment, device-based care and referral each have different roles.

It keeps expectations realistic

Some treatments support comfort or symptoms, but they may not reverse scarring, repair prolapse or remove the need for monitoring.

It supports safer follow-up

Persistent, worsening or changing symptoms should be reviewed rather than repeatedly self-managed.

Calm, practical care

A strong page should help patients understand what may be common, what needs review and what questions to bring to consultation.

It should validate symptoms without turning normal variation or manageable conditions into fear.





Considerations

What to consider

First-Line Therapy: The gold standard treatment is an ultrapotent topical corticosteroid (e.g., 0.5g fingertip unit of Clobetasol propionate 0.05% ointment) applied specifically to non-hair-bearing vulval skin [14, 16, 33]. Hygiene Adjustments: Patients must stop.

Consultation priorities

The consultation should clarify symptoms, anatomy, medical history, medicines, menopause or cancer-treatment context, previous treatments and any skin changes.

History
Examination
Options
Follow-up

Before treatment

Confirm whether symptoms are due to vulval skin disease, vaginal atrophy, infection, pelvic-floor change, prolapse or another cause.

Treatment boundaries

Device treatments, complementary therapies and self-care should not be presented as substitutes for diagnosis or prescribed treatment.

Ongoing care

Long-term symptoms may need maintenance care, flare planning, skin checks or review with a specialist service.

If symptoms change

New bleeding, ulcers, urinary problems, severe pain or visible skin change should be assessed promptly.

What not to assume

Do not assume every intimate symptom is thrush, menopause, laxity or a cosmetic problem.

Costs, treatment course and suitability should be confirmed through WHC guidance or consultation rather than competitor claims.





Common concerns and myths

Common misconceptions

Online advice can make intimate symptoms sound simpler than they are. These corrections keep the page clinically safer.

Myth: Low libido means the problem is not medical

Reality: assessment is needed before deciding whether this applies to your symptoms.

Myth: LS directly explains every desire change

Reality: symptom control, tissue care and long-term review can be separate issues.

Myth: Treatment should promise sexual desire

Reality: supportive measures may help comfort, but they should not delay appropriate medical review.

Diagnosis comes first

The same symptom can come from skin inflammation, low-oestrogen change, infection, pelvic-floor guarding or prolapse.

Treatment should be proportionate

A safe plan may include reassurance, skin care, prescribed treatment, physiotherapy, device treatment or specialist referral depending on the diagnosis.





Safety checklist

Safety checklist

Use these checks to decide whether to monitor, book review, pause treatment or seek urgent advice.

Is this new or changing?

New pain, bleeding, ulcers, colour change or altered vulval architecture should be checked.

Is there a known diagnosis?

Treatment advice is safer when it is based on examination rather than assumptions.

Are symptoms affecting daily life?

Pain with sex, exercise, urination, clothing or washing is worth discussing.

Do you know red flags?

Severe pain, heavy bleeding, urinary difficulty, fever, spreading redness or non-healing ulcers need advice.

More reassuring signs

Symptoms that are mild, improving, already assessed and supported by a clear care plan are more reassuring.

Improving
Known plan
Review booked

Reasons to seek advice

Cancer Risk: There is a small but notable lifetime risk (<5%) of VLS progressing to vulval squamous cell carcinoma (skin cancer) [6, 16, 17]. Urgent Referrals (Red Flags): Clinicians must refer patients for an.

Severe pain
Bleeding
Skin change




When to escalate

When to seek medical help

Some intimate symptoms need prompt advice because early assessment can prevent delay in the right care.

Use NHS 111 online

Severe pain or rapid worsening

Sudden severe pain, rapidly worsening symptoms or difficulty passing urine should be assessed promptly.

Bleeding, ulcers or suspicious skin change

Unexplained bleeding, non-healing ulcers, new lumps, colour change or scarring should not be ignored.

Infection signs

Fever, spreading redness, pus, feeling unwell or significant swelling needs medical advice.

Emergency symptoms

Call 999 for life-threatening symptoms such as collapse, chest pain, breathing difficulty or severe allergic reaction.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Additional clinical context

How the research was used

The Stage A reports, source guide, benchmark synthesis and payload were read before assembly. Promotional wording was softened where it risked turning a clinical question into a sales claim.

Why the page stays cautious

Intimate symptoms need precise language. The page keeps vulval skin, vaginal tissue, pelvic-floor symptoms and treatment suitability separate so the advice remains useful without overpromising.

Next step

Book a confidential consultation

A consultation can review skin control, pain with sex, tearing, libido concerns, lubricant use, pelvic-floor symptoms and whether additional support would help.

View Research Sources (12 Sources)
• NHS - Lichen sclerosus
• RCOG - Skin conditions of the vulva
• British Association of Dermatologists - Lichen sclerosus in females
• NHS - Vaginal dryness
• BSSVD - Vulval lichen sclerosus follow-up guidance
• Pelvic Obstetric and Gynaecological Physiotherapy
• Skin conditions of the vulva | RCOG - Information for you
• The Impact of Vulvar Lichen Sclerosus on Sexual Dysfunction - PMC - NIH
• VULVAL LICHEN SCLEROSUS- GUIDANCE FOR HEALTH CARE PROFESSIONALS (HOSPITAL TEAM OR GP SPECIAL INTEREST) - BSSVD
• Effects of Vulval Lichen Sclerosus on sex and intimacy - Oxford University Hospitals
• Information for patients/carers How to treat lichen sclerosus - BSSVD
• Living with vulval lichen sclerosus: a qualitative interview study - University of Warwick

These 12 source names are selected from 8 display-ready sources, with a raw audit trail of 10 imported records. Additional reviewed material included UK clinical guidance; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.